Products

What will AGI do for Amanozine?

This classification denotes a diuretic with the molecular formula C9H9N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X43W7JDA8L, chemically known as 1,3,5-triazine-2,4-diamine, n-phenyl-, monohydrochloride but generally known as amanozine, which bears US NIH Compound Identifier 10832. Amanozine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amanozine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05388MIG. The term AMANOZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). AMANOZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amanozine under HS 29336980 and SITC 51576. As of Q4 2014, AMANOZINE remains the US FDA Preferred Term for this commodity. Amanozine bears US NLM identifiers UMLS ID C2698079 and NCI Concept Code C74253. SMILES: N(C1CCCCC1)C1NC(NCN1)N.